SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-207604
Filing Date
2021-07-02
Accepted
2021-07-02 16:09:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B4 d134686d424b4.htm 424B4 645808
2 GRAPHIC g134686g38a30.jpg GRAPHIC 79122
3 GRAPHIC g134686g94j64.jpg GRAPHIC 35104
  Complete submission text file 0001193125-21-207604.txt   801053
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-257476 | Film No.: 211070080
SIC: 2836 Biological Products, (No Diagnostic Substances)